Search
Search
| Catalog Number | Quantity |
|---|---|
| 456750010 | 1g |
| 456750050 | 5g |
General Description
• Lopinavir is a retroviral protease inhibitor that acts as an antiretroviral and can prevent the propagation of human immunodeficiency virus (HIV) and hepatitis viruses within cells
• Lopinavir is a dicarboxylic acid diamide and a substituted form of amphetamine
Applications
• Lopinavir may be used in the laboratory study of other retroviruses
• Lopinavir is suitable for laboratory research of drug delivery systems; some studies have shown that the activity of lopinavir can be enhanced by alternative delivery methods such as microencapsulation
Literature References
Hosseini, F.S.; Malektojari, A.; Ghazizadeh, S.; Hassaniazad, M.; Davoodian, P.; Dadvand, H.; Nikpoor, A.R.; Nikoofal-Sahlabadi, S.; Kahoori, S.; Sepandi, M.; Hassanipour, S.; Fathalipour, M. The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2021, 22(1),4. Ansari, H.; Singh, P. Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV. Curr HIV Res. 2018, 16(4), 270-279.